Press Releases

CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of John T. Potts, MD, DSc, to its Board of Directors. Dr. Potts' distinguished, five-decade ca

BOSTON, Oct. 21, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced that the Company will host a Cystic Fibrosis Summit. The event, ti

DUBLIN, Oct. 21, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a clinical research collaboration with Fred Hutchinson Cancer Research Center (

BILLERICA, Mass., Oct. 21, 2019 /PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2019 financial results on Thursday, October 31, 2019, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results a

IRVINE, Calif., Oct. 21, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced select unaudited preliminary financial results for the third quarter ended September 30, 2019.

SHANGHAI, Oct. 21, 2019 /PRNewswire/ -- Goodbaby International Holdings Limited ("Goodbaby"), a world-leading parenting products company, has unveiled a new brand strategy during its 30th anniversary brand conference at the China Kids Expo ("CKE"), held on October 16 at the Shanghai New International Expo Center. Following its CKE the

SAN DIEGO, Oct. 21, 2019 /PRNewswire/ -- i2020 Accelerator announced today its plans to invest in a cutting-edge research program based out of the University of Turku (UTU), Finland. The program studies previously unrecognized protein-protein interactions that disrupt The N-methyl-D-aspartate receptor

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplement to the New Drug Application for Orenitram® (treprostinil) Extended-Release Tablets reflecting data from the FR

HALIFAX, Nova Scotia, Oct. 21, 2019 /PRNewswire/ -- Densitas Inc., a leading provider of AI technologies for digital mammography, announced today that its FDA-cleared de

OSLO, Norway, Oct. 21, 2019 /PRNewswire/ -- Reference is made to the stock exchange announcement on 18 October 2019 regarding the successful completion of Nordic Nanovector ASA's (OSE: NANO) (the "Company") private placement of new shares (the "Private Placement") The Private Placement is divided into two tranches, as further explained in th